CRISPR activation enables high-fidelity reprogramming into human pluripotent stem cells

Juho Joonas Sokka, Masahito Yoshihara, Jouni Kvist, Laura Laiho, Andrew Warren, Christian Stadelmann, Eeva-Mari Jouhilahti, Helena Kilpinen, Diego Balboa, Shintaro Katayama, Aija Kyttälä, Juha Kere, Timo Otonkoski, Jere Weltner, Ras Trokovic

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Sammanfattning

Conventional reprogramming methods rely on the ectopic expression of transcription factors to reprogram somatic cells into induced pluripotent stem cells (iPSCs). The forced expression of transcription factors may lead to off-target gene activation and heterogeneous reprogramming, resulting in the emergence of alternative cell types and aberrant iPSCs. Activation of endogenous pluripotency factors by CRISPR activation (CRISPRa) can reduce this heterogeneity. Here, we describe a high-efficiency reprogramming of human somatic cells into iPSCs using optimized CRISPRa. Efficient reprogramming was dependent on the additional targeting of the embryo genome activation-enriched Alu-motif and the miR-302/367 locus. Single-cell transcriptome analysis revealed that the optimized CRISPRa reprogrammed cells more directly and specifically into the pluripotent state when compared to the conventional reprogramming method. These findings support the use of CRISPRa for high-quality pluripotent reprogramming of human cells.
Originalspråkengelska
TidskriftStem cell reports
Volym17
Nummer2
Sidor (från-till)413–426
Antal sidor14
ISSN2213-6711
DOI
StatusPublicerad - 8 feb. 2022
MoE-publikationstypA1 Tidskriftsartikel-refererad

Vetenskapsgrenar

  • 1184 Genetik, utvecklingsbiologi, fysiologi
  • 1182 Biokemi, cell- och molekylärbiologi

Citera det här